Information for "Evaluation of belimumab therapy in patients with endemic lupus erythematosus in the scientific exercise setting Is caused by the 24month OBSErve review in Argentina"
From EECH Central
Basic information
| Display title | Evaluation of belimumab therapy in patients with endemic lupus erythematosus in the scientific exercise setting Is caused by the 24month OBSErve review in Argentina |
| Default sort key | Evaluation of belimumab therapy in patients with endemic lupus erythematosus in the scientific exercise setting Is caused by the 24month OBSErve review in Argentina |
| Page length (in bytes) | 3,773 |
| Page ID | 1440073 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Caseeggnog6 (Talk | contribs) |
| Date of page creation | 10:21, 5 May 2024 |
| Latest editor | Caseeggnog6 (Talk | contribs) |
| Date of latest edit | 10:21, 5 May 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
